Lysosomes have traditionally been viewed as degradative organelles, although a growing body of evidence suggests that they can function as Ca 2+ stores. Here we examined the function of these stores in hippocampal pyramidal neurons. We found that backpropagating action potentials (bpAPs) could elicit Ca 2+ release from lysosomes in the dendrites. This Ca 2+ release triggered the fusion of lysosomes with the plasma membrane, resulting in the release of Cathepsin B. Cathepsin B increased the activity of matrix metalloproteinase 9 (MMP-9), an enzyme involved in extracellular matrix (ECM) remodelling and synaptic plasticity. Inhibition of either lysosomal Ca 2+ signaling or Cathepsin B release prevented the maintenance of dendritic spine growth induced by Hebbian activity. This impairment could be rescued by exogenous application of active MMP-9. Our findings suggest that activity-dependent exocytosis of Cathepsin B from lysosomes regulates the longterm structural plasticity of dendritic spines by triggering MMP-9 activation and ECM remodelling.
INTRODUCTION
Lysosomes are classically viewed as degradative organelles (Luzio et al., 2007b) . Several studies, however, have demonstrated that lysosomes, along with other related acidic organelles, comprise additional sources of intracellular Ca 2+ . Notably, these sources are distinct from the endoplasmic reticulum (ER) and mitochondria (Galione, 2015) . In this paper, we use the term lysosome to collectively refer to the lysosome and its related acidic organelles. Ca 2+ signaling from lysosomes has now been described in a number of cell types (Galione et al., 2010 (Galione et al., , 2015 . Ca 2+ storage in the lysosome requires an H + gradient, which is generated by a vacuolar H + -ATPase (V-ATPase), and some form of Ca 2+ /H + exchange (Morgan et al., 2011) . Ca 2+ release from the lysosomes requires the second messenger nicotinic acid adenine dinucleotide phosphate (NAADP), which is synthesized, most likely by ADP-ribosyl cyclases, in response to cell-specific physiological stimuli (Galione et al., 2010 (Galione et al., , 2015 . NAADP-dependent Ca 2+ efflux from lysosomes is thought to occur either via transient receptor potential cation channels of the mucolipin 1 family (TRPML1) or via two-pore channels (TPC1/TPC2) (Guse, 2012) , with the weight of evidence currently suggesting that NAADP acts via TPCs, most likely via an NAADP-associated binding protein (Morgan and Galione, 2014; Morgan et al., 2015b) .
NAADP-dependent lysosomal Ca 2+ signaling is likely to play a role in neurons. NAADP binding sites have been found throughout the brain (Patel et al., 2000) , and NAADP synthesis and lysosomal Ca 2+ release in neurons can be triggered by exogenous stimulation with glutamate (Pandey et al., 2009) . Moreover, application of NAADP elicits Ca 2+ release in brain microsomes (Bak et al., 1999) , promotes neuronal differentiation in PC12 cells (Brailoiu et al., 2006) , augments neurite outgrowth in developing cortical neurons (Brailoiu et al., 2005) , drives membrane depolarization in medullary neurons , and increases Ca 2+ influx through N-type voltage-gated Ca 2+ channels (VGCCs) in cultured hippocampal neurons (Hui et al., 2015) . Lysosomes have also been found in axonal boutons, and pharmacologically induced Ca 2+ release from these organelles can drive spontaneous neurotransmitter release (Brailoiu et al., 2003; McGuinness et al., 2007) . Lysosomal Ca 2+ release, however, has not been investigated in postsynaptic structures or in the context of synaptic plasticity. In addition to mediating Ca 2+ signaling, the lysosome itself can also undergo Ca 2+ -dependent fusion, both with other organelles and with the plasma membrane (Luzio et al., 2007b) . In the latter case, lysosomal exocytosis can be important in some cell types for the secretion of chemical signals or enzymes (Blott and Griffiths, 2002; Zhang et al., 2007; Galione et al., 2010; Davis et al., 2012; Galione, 2015) or for promoting lipid turnover and facilitating membrane growth and repair (Reddy et al., 2001; Blott and Griffiths, 2002; Luzio et al., 2007b) . Although not well studied, lysosomal fusion has been reported in developing hippocampal and sympathetic neuronal cultures, where it regulates the surface expression of N-type VGCCs and the outgrowth of neurites, respectively (Arantes and Andrews, 2006; Hui et al., 2015) . However, it is not clear what physiological trigger drives lysosomes to fuse with the plasma membrane or the significance of this fusion for information processing in neurons.
Here we examined the role of lysosomes in hippocampal pyramidal neurons. We found that lysosomal Ca 2+ signaling and lysosomal fusion with the plasma membrane were driven by backpropagating action potentials (bpAPs) and were necessary for the long-term structural plasticity of dendritic spines.
RESULTS

Lysosomes Contribute to bpAP-Evoked Dendritic Ca 2+ Signaling
We began by examining the distribution of lysosomes in hippocampal pyramidal neurons. To do so, we incubated hippocampal slice cultures with LysoTracker red (50 nM, 40-60 min), a fluorescent dye that preferentially labels lysosomal compartments (Chazotte, 2011) . We found LysoTracker-labeled puncta throughout the dendritic arbor of CA3 and CA1 neurons and in some dendritic spines ( Figure 1A ). To confirm that LysoTracker fluorescence was specific for lysosomes, we used glycyl-L-phenylalanine 2-naphthylamide (GPN, 200 mM, 5-10 min) to selectively disrupt lysosomal compartments. GPN is a cell-permeable substrate for the lysosome-specific enzyme Cathepsin C. When cleaved, GPN becomes membrane-impermeable and exerts an osmotic effect that disrupts the lysosomal membrane, leading to the leakage of small molecules out of the organelle (Penny et al., 2014) . We found that addition of GPN abolished the vast majority of LysoTracker fluorescence in cells (n = 5 cells; Mann-Whitney test, p < 0.01; Figure 1B ), suggesting that LysoTracker was predominantly labeling lysosomal compartments. Notably, GPN-induced disruption of the lysosomal membrane was not accompanied by any detrimental effects on neuronal morphology ( Figure 1A ), resting membrane potential, conductance, and intracellular pH ( Figures S1 and S2) .
We next examined whether lysosomes contributed to dendritic Ca 2+ signaling during neuronal activity. We loaded CA3
and CA1 neurons with the Ca 2+ -sensitive dye Oregon Green BAPTA-1 (OGB-1) and imaged dendritic Ca 2+ in response to single bpAPs ( Figure 1C ). bpAP-evoked Ca 2+ influx is thought to be predominantly, if not exclusively, mediated by VGCCs (Jaffe et al., 1992; Christie et al., 1995; Spruston et al., 1995; Helmchen et al., 1996) . However, we found that GPN, despite having no effect on the action potential waveform (Figure S1 ), significantly reduced the Ca 2+ rise evoked by a single bpAP (in %DF/F; artificial cerebrospinal fluid [ACSF], 153 ± 11; GPN, 103 ± 10; n = 18 cells; post hoc Dunn's test, p < 0.01; Figures 1C-1E) ; these reductions were found throughout the dendritic arbor ( Figure 1D ) and were also present in acute hippocampal slices (n = 6 cells; post hoc Dunn's test, p < 0.05; Figures 2E and 2F ). In contrast, application of vehicle control (DMSO) alone had no effect on bpAP-evoked Ca 2+ transients (n = 7 cells; post hoc Dunn's test, p = 0.99; Figure 1E ).
Lysosomal Ca 2+ Release Requires NAADP
To confirm that neuronal activity could trigger Ca 2+ release from the lysosomes, we used additional means of pharmacologically impairing lysosomal Ca 2+ signaling (Galione, 2015; Morgan et al., 2015a ; Figure 8B ). We started by specifically inhibiting lysosomal Ca 2+ storage, which requires a proton gradient to be established by V-ATPases (Morgan et al., 2011) . To disrupt this gradient, we bath-applied the membrane-permeable Na + /H + ionophore monensin (20 mM, 5-10 min). Monensin reduced the bpAP-evoked Ca 2+ transient (in %DF/F; ACSF, 179 ± 24; monensin, 100 ± 14; n = 6 cells; Mann-Whitney test, p < 0.05; Figure 2A ) despite having no effect on action potential waveform (Figure S1 ). However, as previously reported, application of monensin resulted in membrane hyperpolarization ( Figure S1 ), likely related to a modest alkalization of intracellular pH ( Figure S2 ; Ereci nska et al., 1991) . Therefore, we conducted additional experiments in which lysosomal Ca 2+ storage was disrupted using the V-ATPase inhibitor bafilomycin. Given the poor membrane permeability of the drug, we pre-incubated slices with bafilomycin (4 mM, 1-2 hr). This had no effect on the action potential waveform or on the resting membrane potential ( Figure S1 ) but caused a significant decrease in the bpAP-associated Ca 2+ signal that was comparable in magnitude to the decrease obtained in monensin (n = 6 cells/condition; bafilomycin versus control; post hoc Dunn's test, p < 0.05; Figure 2B ). Notably, subsequent addition of GPN resulted in no further reduction in the Ca 2+ signal (n = 6 cells; bafilomycin versus GPN, post hoc Dunn's test, p = 0.99; Figure 2B ), suggesting that the effects of bafilomycin were due to its inhibition of the proton gradient in lysosomes as opposed to other organelles. We next inhibited lysosomal Ca 2+ release. Lysosomal Ca 2+ release requires NAADP, which most likely acts on TPCs (Morgan et al., 2015b) . Although low concentrations of NAADP (10-100 nM) evoke Ca 2+ efflux from the lysosome, higher concentrations (>100 mM) inhibit it via desensitization of the Ca 2+ release machinery (Berg et al., 2000; Masgrau et al., 2003) . Consistent with this, we found that a concentration of 1 mM NAADP in the patch electrode could inhibit lysosomal Ca 2+ release in hippocampal neurons ( Figure S3 ). We also found that this concentration of NAADP reduced the bpAP-evoked Ca 2+ signal (in %DF/F; ACSF, 158 ± 10; NAADP desensitization, 110 ± 11; n = 5 cells; post hoc Dunn's test, p < 0.05; Figure 2C ) and occluded the effects of GPN (n = 5 cells; NAADP versus GPN, post hoc Dunn's test, p = 0.94; Figure 2C ). Similar reductions in Ca 2+ influx were also observed with the cell-permeable NAADP antagonist NED-19 (100 mM, 30-to 60-min pre-incubation; n = 10 cells; Mann-Whitney test, p < 0.01; Figure 2D ). NED-19 also decreased the bpAP-associated Ca 2+ signal in acute hippocampal slices (n = 6 cells; post hoc Dunn's test, p < 0.05; Figure 2E ), and, again, such reductions occluded the effects of GPN (n = 6 cells; NED-19 versus GPN, post hoc Dunn's test, p = 0.48; Figure 2E ).
Notably, drug-induced decreases in bpAP-evoked Ca 2+ release did not result from direct inhibition of VGCC currents ( Figure S4 ) or by affecting Ca 2+ handling ( Figure S5 ) but were likely due to inhibition of lysosomal Ca 2+ signaling itself. One possibility is that the lysosomal Ca 2+ release machinery may be directly voltage-sensitive (Rybalchenko et al., 2012; Cang et al., 2014; Pitt et al., 2014) . Alternatively, lysosomes may sense voltage indirectly via functional coupling with plasma membrane voltage-gated channels. This coupling may be direct, as in the case of the mechanical coupling between ryanodine receptors and VGCCs in striated muscle (Sandow, 1952) . This coupling may also be indirect and mediated by a second messenger such as Ca
2+
. Indeed, it is known that Ca 2+ can trigger NAADP-dependent lysosomal Ca 2+ release (Patel et al., 2001; Morgan et al., 2013) , potentially by directly activating TPCs (Pitt et al., 2010 (Pitt et al., . 2014 Figure 3B ) compared with unstimulated controls (n = 6). As a positive control, to ensure that our experimental setup was sensitive enough to detect lysosomal Ca 2+ transients if present, we included low, physiologically relevant concentrations of NAADP (10-100 nM) in our recording electrode to directly trigger Ca 2+ release from the lysosomes (Calcraft et al., 2009; Figure S3 Galione et al., 2010; Morgan and Galione, 2014) . Previous studies, however, have demonstrated that the ER does not contribute to bpAP-evoked Ca 2+ transients (Markram et al., 1995; Emptage et al., 1999; Kovalchuk et al., 2000) , arguing against lysosome-ER coupling in neuronal dendrites. In line with this, we found that blocking ER Ca 2+ signaling with either ryanodine (20 mM, 20 min) or thapsigargin (15 mM, 20 min) had no effect on the amplitude of bpAP-evoked Ca 2+ transients (n = 5 cells/condition; Kruskal-Wallis test, p > 0.05; Figures 3C  and 3D ). In a subset of experiments with thapsigargin, subsequent addition of GPN resulted in the expected reduction of bpAP-evoked Ca 2+ signaling (n = 3 cells; paired t test, p < 0.05;
Figures 3C and 3D). Collectively, these findings suggest that the ER is unlikely to play a role in bpAP-evoked lysosomal Ca 2+ release.
We also examined the possibility that lysosomal Ca 2+ release was coupled to mitochondrial Ca 2+ stores. Consistent with a previous report (Markram et al., 1995) , application of the mitochondrial uncoupler FCCP (1 mM, 5 min) had no effect on bpAP-evoked Ca 2+ transients (n = 5 cells; Kruskal-Wallis test, p > 0.05; Figure 3D ) and failed to occlude the effects of GPN (n = 5 cells; paired t test, p < 0.05; Figure 3D ). These findings suggest that, under our experimental conditions, the lysosome is the only internal Ca 2+ store that contributes to bpAP-evoked Ca 2+ signaling and is functionally coupled to VGCCs.
Lysosomal Ca 2+ Signaling Drives Fusion of the Lysosomes with the Plasma Membrane
What might be the function of lysosomal Ca 2+ release in neurons? The lysosome itself is known to undergo Ca 2+ -dependent fusion both with other organelles and with the plasma membrane (Luzio et al., 2007b) . The source of Ca 2+ in such instances can be Figure S3 .
the lysosome itself (Pryor et al., 2000; Luzio et al., 2007a Luzio et al., , 2007b Davis et al., 2012; Galione, 2015) . Lysosomal fusion to the plasma membrane has been shown to release chemical messengers or enzymes in several cell types (Luzio et al., 2007b; Galione, 2015) . If present in neurons, such a mechanism could have implications for activity-dependent processing in dendrites. Additionally, our finding of the strong functional coupling between VGCC activation and lysosomal Ca 2+ release in neurons suggests that lysosomes would be ideally situated for activity-dependent fusion with the plasma membrane, akin to synaptic vesicles in the presynaptic terminal.
We investigated whether activity-dependent release of Ca 2+ from the lysosome could trigger fusion of the lysosome to the plasma membrane in neuronal dendrites. We started by using total internal reflection fluorescence microscopy (TIRFM) to monitor the dynamics of LysoTracker-stained lysosomes near the plasma membrane in dissociated hippocampal cultures. We found weak LysoTracker labeling in the dendrites under baseline conditions ( Figure 4A ). However, when we elevated extracellular K + to 45 mM to drive strong dendritic depolarization and VGCC activity (Wu et al., 2001a (Wu et al., , 2001b , we observed a marked increase in the intensity of labeled puncta (Figure 4B ) and an overall increase in surface fluorescence (6.50%DF/F ± 0.05%DF/F; n = 5 cells; z test versus 0, p < 0.01; Figure 4A ; Movie S1). Depolarization had no such effects on cells pre-incubated with NED-19, and, instead, only decreases in fluorescence were observed because of the effects of photobleaching (À1.62%DF/F ± 0.76%DF/F; n = 5 cells; NED-19 versus K + , Mann-Whitney test, p < 0.05; Figures 4A and 4B ).
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These findings suggest that membrane depolarization mobilized lysosomes close to the cell surface and in a manner dependent on lysosomal Ca 2+ signaling; however, from these data alone, we could not determine whether such mobilization was followed by fusion of the lysosome with the plasma membrane.
We next used live-cell immunolabeling in dissociated neurons to examine whether lysosomes were capable of fusing with the plasma membrane in an activity-dependent manner. We applied a fluorescently labeled antibody targeting the lumenal domain of the lysosome-associated membrane protein LAMP-2 during K + -mediated depolarization. Under these conditions, fluorescent labeling of LAMP-2 would require lysosomes to fuse with the plasma membrane ( Figure 4C ). Using this technique, we found that membrane depolarization resulted in significantly greater amounts of immunofluorescence in the dendrite compared with control conditions (in arbitrary fluorescence units [AFU]; K + , 35 ± 4; control, 24 ± 2; n = 23 cells/condition; post hoc Dunn's test, p < 0.05; Figure 4D ). Knocking out LAMP-2 using CRIPSR/Cas9 abolished all surface labeling, confirming that immunofluorescence was specifically associated with LAMP-2 labeling ( Figure S6 Figure 4D ). These findings suggest that neuronal depolarization drives lysosomal fusion with the plasma membrane and in a manner dependent on activity-evoked lysosomal Ca 2+ release. To image lysosomal fusion with improved rapidity and sensitivity, we made use of superecliptic pHlourin (SEP), a pH-sensitive GFP that is commonly used as a probe for synaptic vesicle fusion. We tagged SEP to the lumenal domain of LAMP-2 (Figure 5A ). The fluorescence of LAMP2-SEP, which would be otherwise quenched in the acidic environment of the lysosome, should be detected upon exposure to the pH neutral environment of the extracellular fluid following lysosomal fusion with the plasma membrane. We expressed LAMP2-SEP in dissociated cultures. LAMP2-SEP localized to lysosomes, retained its pH sensitivity, and exhibited maximal fluorescence upon de-acidification of the lysosome with NH 4 Cl ( Figure S7 ). Moreover, upon K + stimulation, we observed a large and rapid increase in LAMP2-SEP fluorescence throughout the dendritic arbor (68%DF/F ± 17%DF/F; n = 5 cells; versus baseline; Mann-Whitney test, p < 0.05; Figures 5B-5D ). This was followed ures 5B and 5C; Movie S2), likely reflecting the surface retrieval and re-acidification of LAMP-2. Fusion of the lysosome with the plasma membrane in several cell types has previously been shown to require the actions of synaptotagmin 7 (Syt7) and can be blocked by loading cells with the cytosolic domain of Syt7 (Martinez et al., 2000; Luzio et al., 2007b) . Therefore, to confirm that increases in LAMP2-SEP fluorescence reflected bona fide fusion of the lysosome with the plasma membrane, we loaded cells with the cytosolic domain of recombinant Syt7 (100 mg/mL). Under these conditions, we detected no increases in fluorescence following K + treatment (n = 5 cells;
Syt7 versus control, post hoc Dunn's test, p < 0.05; Figures 5C  and 5D ). Increases in fluorescence were also abolished by NED-19 (n = 7 cells; versus control, post hoc Dunn's test, p < 0.05; Figures 5C and 5D ), even when Ca 2+ influx from VGCCs Figures 5C and 5D ). These findings confirm that LAMP2-SEP can detect fusion of lysosomes with the plasma membrane and that Ca 2+ release from lysosomal stores is integral for the fusion of the lysosome with the plasma membrane even when Ca 2+ influx from VGCCs is augmented. LAMP2-SEP gave us the added advantage of examining whether lysosome fusion could be triggered by dendritic depolarization evoked by bpAPs. Because we could not reliably detect increases in LAMP2-SEP fluorescence to a single bpAP, we made use of the alkaline trap method (Grubb and Burrone, 2009) , which blocks vesicle re-acidification with the V-ATPase inhibitor bafilomycin. This would enable fusion-mediated increases in LAMP2-SEP fluorescence, if present, to accumulate to measurable levels during repeated stimulation despite LAMP-2 surface retrieval ( Figure 5E ). It is important to mention that, although chronic incubation (>60 min) of bafilomycin inhibited lysosomal Ca 2+ signaling ( Figure 2B ), acute applications had no effect, likely because of the poor membrane permeability of the drug. In keeping with this, brief application of bafilomycin (<10 min) in the absence of any electrical stimulation produced no change in LAMP2-SEP fluorescence (n = 6 cells; z test versus 0, p = 0.93; Figure 5G ), suggesting that the drug alone had no effect on lysosomal pH. However, we did observe robust increases in fluorescence when bafilomycin application was followed by low-frequency (5-Hz) stimulation of 300 bpAPs, which was achieved using field electrodes (27%DF/F ± 6%DF/F; n = 6 cells; versus no stimulation; post hoc Dunn's test, p < 0.01; Figures 5F  and 5G ). No such increases were observed when stimulation was delivered in the presence of NED-19 (n = 7 cells; versus no stimulation; post hoc Dunn's test, p = 0.99; Figure 5G ) or following intracellular loading of Syt7 (n = 5 cells; versus no stimulation; post hoc Dunn's test, p = 0.44; Figure 5G ). Our findings suggest that bpAP-evoked lysosomal Ca 2+ release triggers lysosomal fusion with the plasma membrane.
Lysosomal Fusion Results in the Release of Cathepsin B
The fusion of the lysosome with the plasma membrane likely results in the release of its contents into the extracellular space. We hypothesized that the release of lysosomal proteases may be required for the activity-dependent restructuring of the extracellular matrix (ECM). This would be of potential relevance for long-term synaptic changes, which are known to require ECM remodelling (Wlodarczyk et al., 2011; Dziembowska and Wlodarczyk, 2012) . In this regard, Cathepsin B was of particular interest to us. The cathepsins are a family of lysosomal proteases that generally show preferential activation in acidic environments. Cathepsin B, however, exhibits enzymatic activity in both acidic and pH-neutral environments, suggesting that, upon lysosomal fusion, Cathepsin B would likely retain some form of enzymatic activity in the pH-neutral extracellular space (Mort et al., 1984; Linebaugh et al., 1999) .
We first examined whether Cathepsin B could, in fact, be released by neuronal lysosomes in an activity-dependent manner. We incubated dissociated hippocampal neurons with Magic Red Cathepsin B fluorogenic substrate, which fluoresces upon Cathepsin B-mediated cleavage. Application of the substrate resulted in labeling of fluorescent puncta that co-localized with LysoTracker, confirming that active Cathepsin B was ubiquitously present in neuronal lysosomes ( Figure 6A ; Figure S8 ). Magic Red fluorescence also co-localized with Cathepsin B-GFP fluorescence, confirming that it was labeling Cathepsin-B containing compartments ( Figure S8 ). We then stimulated cultures with 45 mM K + and found that this resulted in a loss of Magic Red fluorescence in some of the imaged puncta, consistent with the notion of lysosomal exocytosis, and the loss of Cathepsin B activity from these sites ( Figure 6A) . A similar loss of fluorescence was seen with LysoTracker ( Figure 6A ; Figure S8) . The average loss of Magic Red fluorescence across puncta (À15.6%DF/F ± 1.6%DF/F; n = 226 puncta from 6 cells; Figure 6B ) was significantly greater than in unstimulated cultures (n = 254 puncta from 5 cells; post hoc Dunn's test, p < 0.01; Figure 6B) , and in cultures pre-treated with NED-19 (n = 152 puncta from 5 cells; post hoc Dunn's test, p < 0.01; Figure 6B ). We defined puncta undergoing fusion as those exhibiting a loss of Magic Red fluorescence of >3 SD from the average fluorescent change measured in unstimulated control experiments. Using this metric, we found that, with K + stimulation, the fraction of Cathepsin B puncta undergoing fusion (8.4% ± 1.8%; n = 226 puncta from 6 cells; Figure 6C ) was significantly greater than that found in unstimulated controls (n = 254 puncta from 5 cells; corrected z test, p < 0.01; Figure 6C ) or in cultures pre-treated with NED-19 (n = 152 puncta from 5 cells; versus K + stimulation; corrected z test, p < 0.01; Figure 6C ). Live-cell immunolabeling of synapses with anti-GluA1 antibodies additionally revealed that >95% of Cathepsin B puncta, both the total pool of puncta and those undergoing activity-dependent fusion, were located within 1 mm of a GluA1-labeled punctum ( Figure S8 ), suggesting that Cathepsin B release occurs in the vicinity of synapses.
Cathepsin B Release Activates MMP-9 ECM remodelling is canonically associated with matrix metalloproteinases (MMPs). One means by which Cathepsin B can promote ECM remodelling is by recruiting MMP activity. It does so by cleaving TIMP-1, an endogenous and potent inhibitor of MMP signaling (Kostoulas et al., 1999; Murphy and Lynch, 2012) . We therefore examined whether activity-dependent release of lysosomal Cathepsin B could contribute to ECM remodeling in cultured hippocampal slices. Using an ELISA, we first confirmed whether we could detect activity-dependent elevations of Cathepsin B in the extracellular fluid. Similar to our findings in dissociated neurons, we found that K + treatment elevated extracellular Cathepsin B in hippocampal slices (in a.u.; control,0.19 ± 0.011; n = 8 slices; K + , 0.31 ± 0.006; n = 5 slices; post hoc Bonferroni test, p < 0.01; Figure 6D ). Pre-treatment with NED-19 greatly reduced this activity-dependent increase (n = 7 slices; NED-19 + K + versus K + ; post hoc Bonferroni test, p < 0.01; Figure 6D ), although it did not quite abolish it (n = 7 and 5 slices; NED-19 versus NED-19 + K + ; post hoc Bonferroni test, p < 0.05, Figure 6D ). We next examined whether extracellular Cathepsin B was enzymatically active. To do so, we incubated slices with a Cathepsin B fluorogenic substrate (Z-Arg-Arg-AMC) and monitored increases in extracellular fluorescence as a readout of enzymatic activity ( Figure 6E ). Cathepsin B activity was minimal under control conditions (77 ± 502 AFU; n = 5 slices; z test versus 0, p = 0.87; Figure 6E ), greatly enhanced after K + stimulation (1,717 ± 850 AFU; n = 5 slices; K + versus control; post hoc Bonferroni test, p < 0.05; Figure 6E Figure 6E ). Collectively, these findings are consistent with the activity-dependent release of active Cathepsin B from lysosomal stores.
Cathepsin B is able to activate MMP signaling by cleaving the MMP inhibitor TIMP-1 (Kostoulas et al., 1999; Murphy and Lynch, 2012) . We therefore examined whether activity-dependent release of lysosomal Cathepsin B could mediate an increase in extracellular MMP activity in hippocampal tissue. To examine this, we incubated hippocampal slices with a broadly selective MMP fluorogenic substrate (PEPDAB0502), which fluoresces upon MMP-mediated cleavage (Miller et al., 2011) . We examined MMP-associated fluorescence either in the presence or absence of the membrane-impermeable Cathepsin B inhibitor CA-074 (1 mM), which we used to selectively inhibit extracellular Cathepsin B activity (Linebaugh et al., 1999; Mitrovi c et al., 2016) . Notably, we saw no effect of CA-074 on MMP activity under basal conditions (in AFU; control, 2,083 ± 207; n = 29 slices; CA-074, 1,601 ± 317; n = 15 slices; post hoc Bonferroni test, p = 0.40; Figure 6F ). However, given our finding that Cathepsin B release is activity-dependent, we repeated the experiment under high K + conditions to promote Cathepsin B secretion from lysosomal stores. Under these conditions we found that MMP activity was significantly greater than that of controls (AFU = 4,725 ± 259; n = 13 slices; K + versus control; post hoc Bonferroni test, p < 0.01; Figure 6F ) and now sensitive to Cathepsin B inhibition by CA-074 (AFU = 3,187 ± 317; n = 12 slices; CA-074 versus K + ; post hoc Bonferroni test, p < 0.01; Figure 6F) . These findings are consistent with the idea that activitydependent release of Cathepsin B stimulates MMP activity in hippocampal slices.
Several studies have demonstrated that MMP-9, in particular, is necessary for the maintenance of long-term potentiation (LTP) and dendritic spine growth (Wang et al., 2008; Wlodarczyk et al., 2011; Dziembowska and Wlodarczyk, 2012) . We were therefore interested in examining how Cathepsin B affected MMP-9 activity in hippocampal slices. For this purpose, we again incubated slices with the MMP fluorogenic substrate but did so either in the presence or absence of an MMP-9 inhibitor (100 nM MMP-9 inhibitor I). We took the reduction in MMP-associated fluorescence that occurred in the presence of the inhibitor as a readout of the levels of MMP-9 activity present under a particular condition. Under control conditions, we detected a small but significant level of MMP-9 activity (AFU = 635 ± 220; n = 14 slices; z test, p < 0.01; Figure 6G ). Given that MMP-9 activation is driven by neuronal activity and not normally detectable under baseline conditions (Nagy et al., 2006; , we reasoned that the MMP-9 activity in our experiment was likely driven by spontaneous neuronal activity in our slices. Indeed, we found that MMP-9 activity was abolished in the presence of TTX (n = 9 slices; z test versus 0, p > 0.05; Figure 6G ), although this did not reach significance compared with control levels of activity (post hoc Bonferroni test, p = 0.21). Conversely, elevating neuronal activity by K + stimulation greatly enhanced MMP-9 activity from control levels (AFU = 2,592 ± 439; n = 10 slices; K + versus control; post hoc Bonferroni test, p < 0.01; Figure 6G ). Given that K + stimulation also enhances Cathepsin B release, we asked whether activity-dependent release of Cathepsin B was necessary for the activity-dependent increase in MMP-9 activity. We found that addition of either CA-074, to inhibit extracellular Cathepsin B, or NED-19, to prevent activity-dependent Cathepsin B release, abolished MMP-9 activity in K + stimulated slices (CA-074, n = 11 slices; versus K + ; post hoc Bonferroni test, p < 0.01; NED-19, n = 5 slices; post hoc Bonferroni test, versus K + , p < 0.01; Figure 6G ). Therefore, activity-dependent increase of MMP-9 activity in hippocampal slices requires activity-dependent release of Cathepsin B.
MMP-9 and its endogenous inhibitor TIMP-1 co-localize to secretory vesicles and are co-released with neuronal activity (Nagy et al., 2006; Sbai et al., 2008; . MMP-9 activity, therefore, will not necessarily depend on the absolute levels of MMP-9 in tissue but on the ratio of MMP-9 to TIMP-1. Therefore, to provide additional evidence that Cathepsin B is capable of recruiting MMP-9 activity, we examined the MMP-9/TIMP-1 ratio in hippocampal slices. We reasoned that this ratio should be increased by neuronal activity and in a manner dependent on lysosomal Cathepsin B. In agreement with this, western blot analysis showed a marked increase in the MMP-9/TIMP-1 ratio in slices treated with K + ( Figure S9 ).
Inhibiting Cathepsin B release with NED-19 or Cathepsin B activity with CA-074 inhibited these increases ( Figure S9 ).
Cathepsin B Release Is Necessary for MMP-9-Mediated Long-Lasting Structural Plasticity Long-lasting changes in synaptic function are thought to ultimately require stable, structural changes in the pre-or post-synaptic elements, with LTP induction being associated with longlasting expansion of the postsynaptic density and a stable enlargement of the dendritic spine head. Such changes require ECM remodelling by MMP-9 (Wang et al., 2008; Wlodarczyk et al., 2011; Dziembowska and Wlodarczyk, 2012) . Given that lysosomal-mediated release of Cathepsin B provides a means by which neuronal activity can trigger activation of MMP-9, we hypothesized that the lysosome would play a pivotal role in the maintenance of structural plasticity. We therefore examined the effect that inhibiting lysosomal Ca 2+ signaling and fusion with NED-19 would have on structural enlargements of dendritic spines induced by Hebbian pairing. For this purpose, we filled CA1 neurons with Alexa Fluor 488 dye to visualize spine structure and induced LTP by pairing brief (1 ms) photolysis of caged glutamate on a target spine with 3-5 bpAPs ( Figure 7A ). The pairing was repeated 60 times at 5 Hz. This protocol produced a rapid and long-lasting expansion of the target spine that was present at 1 min following stimulation (foldD = 1.75 ± 0.12; n = 9 cells; z test versus 1.00, p < 0.01; Figures 7B and 7E ) and remained stable for at least 60 min thereafter (n = 9 cells; foldD at 60 min versus 1 min; Mann-Whitney, p = 0.61; Figure 7B ). No enlargements were observed at neighboring spines (n = 9 cells; z test versus 1.00, p = 0.37; Figures 7B and 7E ). Remarkably, NED-19 abolished long-lasting changes in structural growth (n = 6 cells; foldD at 60 min; z test versus 1.00, p = 0.78; Figures 7B and 7E ) despite having no effect on the initial spine growth recorded 1 min after paired stimulation (n = 6 cells; versus control; Kruskal-Wallis, p = 0.29; Figures 7B and 7E) ; similar results were obtained when lysosomal Ca 2+ release was instead inhibited with desensitizing concentrations of NAADP in the recording electrode (n = 6 cells; foldD at 1 min versus (E) Extracellular Cathepsin B activity levels measured in hippocampal slices using the fluorogenic Cathepsin B substrate Z-Arg-Arg-AMC (n = 5 slices/condition). Activity-dependent increases in Cathepsin B activity were abolished by NED-19. Figures 7B  and 7E ). These findings suggest that lysosomal Ca 2+ release and fusion are specifically involved in the maintenance, as opposed to the induction, of structural plasticity; a very similar role has been reported for MMP-9 (Wang et al., 2008) . We hypothesized that the reason why pharmacological impairment of lysosomal function prevented structural plasticity was a failure of the postsynaptic neuron to release Cathepsin B during neuronal activity. Consistent with this idea, we found that inhibition of extracellular Cathepsin B with CA-074, was able to phenocopy the effects of NED-19 (n = 5 cells; foldD at 1 min; CA-074 versus NED-19; post hoc Dunn's test, p = 0.66; foldD at 60 min; CA-074 versus NED-19; post hoc Dunn's test, p = 0.99; Figures 7C and 7E ), whereas exogenous application of active Cathepsin B (5 mg/mL applied for 10 min after the start of pairing) rescued the NED-19 phenotype, restoring persistent expansion of the target spine to control levels (foldD at 60 min = 1.87 ± 0.14; n = 5 cells; versus control; post hoc Dunn's test, p = 0.99; Figures  7C and 7E ) without affecting neighboring spines (n = 5 cells;
Kruskal-Wallis test, p = 0.72; Figures 7C and 7E ). In contrast, addition of active Cathepsin B in control experiments did not further augment spine expansion (n = 5 cells; versus control; post hoc Dunn's test, p = 0.99; Figures 7C and 7E) , suggesting that Cathepsin B activity was not a limiting factor under normal conditions of plasticity induction. To then test whether the function of lysosome fusion and Cathepsin B release, in the context of structural plasticity, was to ultimately activate MMP-9, we attempted to rescue the plasticity deficits induced by CA-074 and NED-19 by exogenous application of active MMP-9 (5 mg/mL applied for 10 min after the start of pairing). We found that MMP-9 did indeed restore persistent expansion of the target spine to control levels in both NED-19-and CA-074-treated slices ( Figures 7D and 7E ), suggesting that the activity of MMP-9, like that of Cathepsin B, was not a limiting factor under normal conditions of plasticity induction.
DISCUSSION
Here we found that dendritic Ca 2+ influx from VGCCs during bpAPs triggered Ca 2+ release from the lysosome. This Ca 2+ release led to the fusion of the lysosome with the plasma membrane, resulting in the release of Cathepsin B and the subsequent recruitment of MMP-9 activity. We found that activitydependent enhancement of MMP-9 signaling by Cathepsin B was necessary for the maintenance of the long-lasting dendritic spine growth that accompanies Hebbian pairing of synaptic activity with postsynaptic bpAPs ( Figure 8A ). Our finding that bpAPs can trigger Ca 2+ release from the lysosome is unexpected because it has long been thought that bpAP-evoked Ca 2+ influx is mediated exclusively by VGCCs with little or no contribution from intracellular stores. The evidence for this comes from the fact that bpAP-evoked Ca 2+ signals are essentially abolished following VGCC inhibition or removal of extracellular Ca 2+ (Jaffe et al., 1992; Christie et al., 1995; Spruston et al., 1995; Helmchen et al., 1996) , whereas inhibition of ER or mitochondrial Ca 2+ signaling is without effect (Markram et al., 1995; Emptage et al., 1999; Kovalchuk et al., 2000) . We found similar effects in our own study when blocking VGCC-, ER-, and mitochondrion-mediated Ca 2+ signaling; however, we were also able to unmask a role for lysosomal stores. (Patel et al., 2001; Morgan et al., 2013) , potentially by directly activating TPCs (Pitt et al., 2010 (Pitt et al., , 2014 ; although the exact mechanism remains unclear, it does suggest that TPCs are regulated both by Ca 2+ and by NAADP. To the best of our knowledge, we are the first to report evidence of a functional coupling between VGCCs and lysosomes, which may potentially be a feature unique to excitable tissue. Certainly, such a coupling is an efficient means of endowing lysosomes with voltage sensitivity, thereby enabling lysosomal Ca 2+ release to be driven by neuronal activity. Although Ca 2+ release from the lysosomes may serve a number of functions, in this study, we found that it drove the fusion of lysosomes with the plasma membrane. Why Ca 2+ release from the lysosome, as opposed to other sources, is particularly important for its fusion with the plasma membrane is not clear, but a similar mechanism is thought to underlie lysosomal exocytosis in other cell types (Davis et al., 2012; Galione, 2015) and suggests that the lysosomal fusion machinery is sensitive to nanodomain Ca 2+ signaling generated locally by the organelle itself.
It is, however, important to note that, from out data alone, we cannot determine whether the lysosomes releasing Ca 2+ in response to bpAPs are those that subsequently undergo fusion with the plasma membrane; it is possible that distinct subpopulations of lysosomes may differentially mediate these functions.
We found that fusion of the lysosome was accompanied by the release of Cathepsin B into the extracellular space. Cathepsin B release has generally been reported in the context of pathological conditions. In neural tissue, excessive levels of extracellular Cathepsin B release have been associated with cell death in traumatic brain injury, brain aneurysm, and several neurologic diseases such as aminotrophic lateral sclerosis (ALS), Alzheimer's disease, Parkinson's disease, and Huntington's disease (Pi slar and Kos, 2014; Hook et al., 2015) . Potential mediators of Cathepsin B release under these conditions include reactive astrocytes, microglia, and/or macrophages (Ryan et al., 1995; Linebaugh et al., 1999; Kingham and Pocock, 2001; Gan et al., 2004; Murphy and Lynch, 2012) . Although the exact mechanism by which these cells release Cathepsin B is not clear, if it involves lysosomal fusion with the plasma membrane, as reported in this study, then pharmacological inhibition of lysosomal Ca 2+ signaling may provide a novel means for preventing excessive Cathepsin B release under pathological conditions. We showed that Cathepsin B release was essential for the maintenance of long-term structural plasticity, likely by recruiting MMP-9 activity via cleavage of TIMP-1 (Kostoulas et al., 1999; Murphy and Lynch, 2012) . Although several studies have demonstrated a role for MMP-9 in long-term synaptic plasticity, the mechanism by which neuronal activity triggers an increase in MMP-9 activity is not completely understood (Wlodarczyk et al., 2011; Dziembowska and Wlodarczyk, 2012) . In the context of LTP, it is known that neuronal stimulation triggers the transport and translation of MMP-9 mRNA in neuronal dendrites, followed by MMP-9 release into the ECM (Nagy et al., 2006; , where it is converted into its active form, likely via plasmin-mediated cleavage of the MMP-9 pro-domain (Wlodarczyk et al., 2011) . However, upon secretion, MMP-9 is complexed with its inhibitor TIMP-1 (Sbai et al., 2008) , which is capable of inhibiting both active and inactive forms of MMP-9 (Ogata et al., 1995) . Inhibition of TIMP-1 signaling, therefore, is likely to be crucial for the maintenance of LTP. Based on our results, we would suggest that the activity-dependent secretion of Cathepsin B from neuronal lysosomes is one possible means by which TIMP-1 signaling can be inhibited (Figure 8 ).
Although traditionally viewed as the degradative compartment of the cell, a growing body of evidence suggests that the lysosome functions as a Ca 2+ store that is capable of mediating a diverse array of physiological functions across numerous cell types (Galione et al., 2010 (Galione et al., , 2015 . In this study, we examined the role of lysosomes in neurons. Our findings reveal that lysosomes mediate activity-dependent Ca 2+ signaling in the dendrites and, via the release of Cathepsin B, play an important and unexpected role in the long-term maintenance of structural plasticity.
EXPERIMENTAL PROCEDURES Hippocampal Tissue Preparation
All animal work was carried out in accordance with the Animals (Scientific Procedures) Act, 1986 (UK) and under project and personal licenses approved by the Home Office (UK). Acute coronal hippocampal slices (350-400 mm) were prepared from male Wistar rats (post-natal day 14 [P14]-P21) and perfused (3 mL/min) with ACSF (120 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 1.2 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 11 mM glucose, 0.2 mM ascorbic acid, and 1 mM Trolox; pH = 7.2-7.4; 32 C-34 C; 95% O 2 and 5% CO 2 ).
Cultured hippocampal slices (350 mm) were prepared from male Wistar rats (P7). Slices (days in vitro [DIV] 10-15) were perfused (1-2 mL/min) with heated ACSF (32 C-34 C). For dissociated cultures, hippocampal cells from P1 male Wistar rats were plated onto 18-mm coverslips (3-6 3 10 4 cells/coverslip), precoated with poly-D-lysine (0.1 mg/mL) and fibronectin (0.05 mg/mL), and imaged on DIV 10-21 in Tyrode's buffer (128 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 4.2 mM NaHCO 3 , 20 mM glucose, and 15 mM HEPES; pH = 7.2-7.4; 22 C-24 C). For K + stimulation, 30 or 45 mM NaCl was replaced with KCl. See Supplemental Experimental Procedures for further details.
Ca
2+ Imaging and Electrophysiology
CA3 or CA1 cells in hippocampal slices were recorded using either sharp microelectrodes (70-120 MU) or high-resistance patch electrodes (16-25 MU) to minimize intracellular dialysis. For Ca 2+ imaging, sharp microelectrodes contained 0.5-1 mM OGB-1 (Thermo Fisher Scientific) dissolved in 200-400 mM potassium acetate. Patch electrodes contained OGB-1 (0.1-0.2 mM) dissolved in internal solution (135 mM KGluconate, 10 mM KCl, 10 mM HEPES, 2 mM MgCl 2 , 2 mM Na 2 ATP, and 0.4 mM Na 3 GTP; pH = 7.2-7.4). Apical dendrites were imaged using confocal laser-scanning microscopy and a 488-nm argon laser. bpAPs were triggered with somatic current injection (1-2 nA, 5-10 ms) and recorded with an AxocLAMP-2B amplifier (Axon Instruments). See Supplemental Experimental Procedures for further details.
Cathepsin B and MMP Assays
Assays were done on slice culture supernatant using a plate reader. Cathepsin B levels were assessed using a colorimetric human Cathepsin B ELISA kit (ab119684, Abcam)according to the manufacturer's instructions. Cathepsin B and MMP activity was assessed by incubating slices either with the Cathepsin B fluorogenic substrate Z-Arg-Arg-AMC (1:200, JA7740, Merck Millipore) or a MMP fluorogenic substrate (5 mM PEPDAB0502, Biozyme) for 2 hr and examining fluorescence in the supernatant. MMP-9 activity levels were calculated as the difference in MMP fluorescence obtained in the absence and presence of an MMP-9 inhibitor (100 nM of MMP-9 inhibitor I 
